A woman of 71 was admitted after 24 hours of fever, headache and confusion. Two weeks previously she had consulted her general practitioner because of palpitations and weight loss of 10 kg, and thyroid function tests had been arranged. On admission she was thin, confused, pyrexial (38.7 8C), tachycardic, tachypnoeic and hypotensive, with a moderate diffuse goitre and bilateral periorbital oedema. Chest X-ray showed bilateral basal bronchopneumonia. Arterial blood gases pointed to type 2 respiratory failure and serum creatinine was 224 mmol/L (reference range 40-125). On transfer to the intensive care unit she received physiotherapy, oxygen and intravenous antibiotics. She improved and was discharged home after 7 days.
Thyroid function tests on admission (day 1) did not confirm the clinical impression of hyperthyroidism. Serum thyroid stimulating hormone, 50.03 mU/L (0.4-4.0), was suppressed but free thyroxine and free triiodothyronine, 7 pmol/L (12-26) and 1.4 pmol/L (55.5) respectively, were low. Investigations were repeated on days 2 and 14. After review of these results and of thyroid function tests arranged before admission (day 714), Graves' hyperthyroidism was diagnosed. Carbimazole 20 mg twice daily was started on day 14 and thyroid function was monitored over the next four weeks (Table 1) . Six weeks after admissions and taking carbimazole, the patient was well with normal thyroid function tests and chest X-ray.
COMMENT
The alteration in serum thyroid hormone concentrations that accompanies illness and starvation is known as nonthyroidal illness syndrome, or NTIS. Almost any severe illness or trauma or short-term episode of starvation causes a fall in serum triiodothyronine (T3) and most acutely ill patients in hospital have a low serum T3. 1 T3 is largely derived from the conversion of thyroxine (T4) in peripheral tissues and this conversion is suppressed. Patients who only show a low serum T3 have the mildest form of NTIS and do not have signs of hypothyroidism. The hyperthyroid patient described here was critically ill on admission to the intensive care unit with bronchopneumonia and had low levels of both T3 and T4. This picture is due to reduced hormone production by the thyroid gland in addition to suppressed peripheral conversion of T4 to T3. Thyroid hormone entry into target cells is also impaired 2 and less T3 is formed locally, with low tissue concentrations of T3 and T4. 3 There was difficulty in interpreting thyroid function tests in this patient, who had symptoms and signs of hyperthyroidism before becoming acutely ill. Thyroid hormone concentrations, previously high, fell during the acute illness to an extent that made free T3 and free T4 measurement unreliable. There is one published report of a similar case. 4 Interest in NTIS goes beyond the physiology. Although there is no evidence that small decreases in T3 increase the probability of death, large changes in thyroid hormone concentrations are associated with excess morbidity. In very ill patients both T3 and T4 are low and T4 concentrations reflect the severity of the illness. Patients with the lowest T4 have the worst prognosis. 5, 8 In a prospective study of 84 patients admitted to intensive care and coronary care units 22% had a low T4. Probability of death was approximately 50% when serum T4 fell below normal and 80% when it was more than 40% below normal. 6 Would thyroid hormone treatment have been beneficial to some of these patients? A large prospective study would be needed to answer this question.
Although a slight increase in serum thyroid stimulating hormone (TSH) may be seen during recovery, TSH in severe NTIS is generally low or normal. 7 The TSH is inappropriately low for the observed T3 and T4. There is therefore reason to believe that hypothalamic function is impaired in NTIS, with a low TSH depressing output of hormones by the thyroid gland. In intensive care, matters are often complicated by use of drugs such as dopamine 8 and glucocorticoids, 9 which reduce thyroid hormone concentrations by suppressing TSH production. Hypothyroidism Pyoderma gangrenosum is an enigmatic disorder of rapidly spreading ulceration virtually indistinguishable from synergistic gangrene. Because management of the two conditions is so different correct diagnosis is crucial.
CASE HISTORY
A woman of 54 underwent breast reduction. Four days postoperatively, oral antibiotics were started for presumed wound infection but her condition worsened and she was admitted with severe pain, foul discharge and general malaise. On examination she was tachycardic, dehydrated and pyrexial (38.58C); both breasts were swollen and tender, with erythema and desquamation well demarcated by purple-blue margins. Suture lines were spared. Initial treatment was wound toilet and broad-spectrum intravenous antibiotics. After forty-eight hours, despite subjective improvement and loss of pyrexia, ulceration had extended (Figure 1 ) and inflammatory markers were raised. A dermatologist suspected pyoderma gangrenosum despite the absence of associated systemic diseases, and ciclosporin 5 mg/kg daily was started. Within forty-eight hours the pain diminished greatly and ulceration ceased to progress. The patient was discharged after twelve days and continued on oral ciclosporin for one month. After six weeks the wounds had epithelialized (Figure 2 ).
COMMENT
Pyoderma gangrenosum is believed to result from a misdirected immune response to injury. 1 As in Behçet's disease, new lesions can develop even after trivial trauma such as venepuncture. Typically the condition first appears in the pretibial area with erythematous pustules which become boggy plaques with violaceous margins and an erythematous halo. There is then rapid progression to cutaneous ulceration and spreading necrosis. The patient is pyrexial and complains of disproportionate pain. A hallmark of the condition is a rapid response to immunosuppressive treatment with ciclosporin or tacrolimus. 2 Healing may be accompanied by atrophic scarring.
